Literature DB >> 20015014

Fluorescent substrates useful as high-throughput screening tools for ADAM9.

Marcia L Moss1, Fred H Rasmussen, Raphael Nudelman, Peter J Dempsey, Jason Williams.   

Abstract

Fluorescence resonance energy transfer substrates were designed and tested as substrates for ADAM9. The donor/quencher pair used were 5-carboxy fluorescein (Fam) and 4-(4-dimethyl-aminophenylazo)benzoyl (Dabcyl) since they have been well studied sensitive fluorescent probes. The peptides based on precursor TNF-alpha, Dabcyl-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Lys(Fam)- NH2 and Dabcyl-Leu-Ala-Gln-Ala-HomoPhe-Arg-Ser-Lys(Fam)- NH2, and C-terminal TGF-alpha, Dabcyl-Glu-His-Ala-Asp-Leu-Leu-Ala-Val-Val-Ala-Ala-Lys(Fam)- NH2 cleavage sites were effectively processed by ADAM9 with turnover numbers of 100 +/- 20 x 10(-2) min(-1), 20 +/- 10 x 10(-2) min(-1), and 10 +/- 3 x 10(-2) min(-1). In addition, a peptide based on the 33 kDa cleavage site of the low affinity receptor for IgE, CD23, Dabcyl-Leu-Arg-Ala-Glu-Gln-Gln-Arg-Leu-Lys-Ser-Lys(Fam)- NH2 was processed as well but with less efficiency. A more selective substrate for ADAM9 was found based on the betacellulin cleavage site. However, the valine containing precursor TNF-alpha based substrate was used to measure IC50 values of metalloproteinase inhibitors against ADAM9 since it was processed the most efficiently. The tightest binding inhibitor was the Wyeth Aerst compound, TMI-1, with an IC50 of 2.1 +/- 0.3 nM. In addition, GI254023, previously identified as a selective inhibitor of ADAM10, also inhibited ADAM9 with an IC50 of 280 +/- 110 nM. These results demonstrate that sensitive substrates for ADAM9 can be developed that are useful in high-throughput screening assays for ADAM9.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20015014     DOI: 10.2174/138620710791054259

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  12 in total

1.  ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.

Authors:  Marcia L Moss; Gary Powell; Miles A Miller; Lori Edwards; Bin Qi; Qing-Xiang Amy Sang; Bart De Strooper; Ina Tesseur; Stefan F Lichtenthaler; Mara Taverna; Julia Li Zhong; Colin Dingwall; Taheera Ferdous; Uwe Schlomann; Pei Zhou; Linda G Griffith; Douglas A Lauffenburger; Robert Petrovich; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

2.  Potential of fluorescent metalloproteinase substrates for cancer detection.

Authors:  Roopali Roy; David Zurakowski; Susan Pories; Marcia L Moss; Marsha A Moses
Journal:  Clin Biochem       Date:  2011-10-06       Impact factor: 3.281

3.  Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.

Authors:  Miles A Miller; Layla Barkal; Karen Jeng; Andreas Herrlich; Marcia Moss; Linda G Griffith; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2010-12-23       Impact factor: 2.192

4.  Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates.

Authors:  Roma Stawikowska; Mare Cudic; Marc Giulianotti; Richard A Houghten; Gregg B Fields; Dmitriy Minond
Journal:  J Biol Chem       Date:  2013-06-18       Impact factor: 5.157

5.  MMP-1 and ADAM10 as Targets for Therapeutic Intervention in Idiopathic Pulmonary Fibrosis.

Authors:  Zhihong Peng; Mohini Mohan Konai; Luis F Avila-Cobian; Man Wang; Shahriar Mobashery; Mayland Chang
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-18

6.  Glycosylation of a disintegrin and metalloprotease 17 affects its activity and inhibition.

Authors:  Anais Chavaroche; Mare Cudic; Marc Giulianotti; Richard A Houghten; Gregg B Fields; Dmitriy Minond
Journal:  Anal Biochem       Date:  2013-12-19       Impact factor: 3.365

7.  Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.

Authors:  Dmitriy Minond; Mare Cudic; Nina Bionda; Marc Giulianotti; Laura Maida; Richard A Houghten; Gregg B Fields
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

8.  ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.

Authors:  Christian Herzog; Randy S Haun; Andreas Ludwig; Sudhir V Shah; Gur P Kaushal
Journal:  J Biol Chem       Date:  2014-03-24       Impact factor: 5.157

9.  Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates.

Authors:  Toshie Yoneyama; Michael Gorry; Miles A Miller; Autumn Gaither-Davis; Yan Lin; Marcia L Moss; Linda G Griffith; Douglas A Lauffenburger; Laura P Stabile; James G Herman; Nikola L Vujanovic
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

10.  A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.

Authors:  Nathalie Wojtalewicz; Elham Sadeqzadeh; Jakob V Weiß; Mahnaz Moradian Tehrani; Susanne Klein-Scory; Stephan Hahn; Wolff Schmiegel; Uwe Warnken; Martina Schnölzer; Charles E de Bock; Rick F Thorne; Irmgard Schwarte-Waldhoff
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.